95.23 - 97.14
55.47 - 103.81
1.63M / 1.81M (Avg.)
55.57 | 1.74
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-18.59%
Both firms have declining sales. Martin Whitman would suspect an industry slump or new disruptive entrants.
-16.62%
Both firms have negative gross profit growth. Martin Whitman would question the sector’s viability or cyclical slump.
-15.52%
Both companies show negative EBIT growth. Martin Whitman would consider macro or sector-specific headwinds.
-15.52%
Both companies face negative operating income growth. Martin Whitman would suspect broader market or cost hurdles.
-18.77%
Both companies face declining net income. Martin Whitman would suspect external pressures or flawed business models in the space.
-18.92%
Both companies exhibit negative EPS growth. Martin Whitman would consider sector-wide issues or an unsustainable business environment.
-18.92%
Both face negative diluted EPS growth. Martin Whitman would suspect an industry or cyclical slump with heightened share issuance across the board.
0.05%
Share count expansion well above FNV's 0.05%. Michael Burry would question if management is raising capital unnecessarily or is over-incentivizing employees with stock.
0.11%
Diluted share count expanding well above FNV's 0.05%. Michael Burry would fear significant dilution to existing owners' stakes.
-44.76%
Dividend reduction while FNV stands at 2.60%. Joel Greenblatt would question the firm’s cash flow stability or capital allocation decisions.
-6.99%
Both companies show negative OCF growth. Martin Whitman would analyze broader economic or industry conditions limiting cash flow.
31.55%
FCF growth under 50% of FNV's 166.96%. Michael Burry would suspect weaker operating efficiencies or heavier capex burdens.
13.95%
10Y revenue/share CAGR under 50% of FNV's 85.73%. Michael Burry would suspect a lasting competitive disadvantage.
12.85%
5Y revenue/share CAGR under 50% of FNV's 71.39%. Michael Burry would suspect a significant competitive gap or product weakness.
42.63%
3Y revenue/share CAGR at 50-75% of FNV's 80.55%. Martin Whitman would question if the firm lags behind competitor innovations.
-5.57%
Negative 10Y OCF/share CAGR while FNV stands at 56.33%. Joel Greenblatt would scrutinize managerial effectiveness and product competitiveness.
21.90%
5Y OCF/share CAGR 1.25-1.5x FNV's 14.98%. Bruce Berkowitz would see if capital spending or working-capital efficiencies explain the difference.
82.91%
3Y OCF/share CAGR 1.25-1.5x FNV's 57.17%. Bruce Berkowitz might see if strategic cost controls or product mix drove recent gains.
-21.60%
Negative 10Y net income/share CAGR while FNV is at 150.42%. Joel Greenblatt sees a major red flag in long-term profit erosion.
59.10%
Below 50% of FNV's 184.39%. Michael Burry would worry about a substantial lag vs. the competitor’s profit ramp-up.
290.73%
3Y net income/share CAGR 1.25-1.5x FNV's 210.28%. Bruce Berkowitz might see new markets, M&A, or better cost discipline driving the difference.
86.13%
10Y equity/share CAGR above 1.5x FNV's 55.79%. David Dodd would confirm if consistent earnings retention or fewer write-downs drive this advantage.
18.37%
5Y equity/share CAGR at 50-75% of FNV's 29.72%. Martin Whitman would question a shortfall in capital accumulation vs. the competitor.
14.03%
3Y equity/share CAGR at 50-75% of FNV's 19.64%. Martin Whitman sees a short-term lag in net worth creation vs. the competitor.
323.53%
10Y dividend/share CAGR above 1.5x FNV's 104.54%. David Dodd checks if the firm's robust cash flows justify outpacing the competitor's increases.
190.02%
5Y dividend/share CAGR above 1.5x FNV's 44.63%. David Dodd checks if the firm's mid-term cash flows justify a faster dividend growth rate.
66.46%
3Y dividend/share CAGR above 1.5x FNV's 33.29%. David Dodd sees a superior short-term capital return strategy if supported by stable earnings.
-24.73%
Firm’s AR is declining while FNV shows 27.74%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
280.32%
We show growth while FNV is shrinking stock. John Neff wonders if the competitor is more disciplined or has weaker demand expectations.
1.09%
Asset growth above 1.5x FNV's 0.50%. David Dodd checks if M&A or new capacity expansions are value-accretive vs. competitor's approach.
0.97%
BV/share growth above 1.5x FNV's 0.46%. David Dodd confirms if consistent profit retention or fewer write-downs yield faster equity creation.
-7.67%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
No Data
No Data available this quarter, please select a different quarter.
-36.65%
Both reduce SG&A yoy. Martin Whitman sees a cost war or cyclical slowdown forcing overhead cuts.